OSI Pharmaceuticals EVP to present portfolio at diabetes and obesity conference


MELVILLE, N.Y. OSI Pharmaceuticals, Inc. announced Thursday that Anker Lundemose, M.D., EVP of OSI Pharmaceuticals will present at the Canaccord Adams Conference in New York, N.Y. on Tuesday, May 12, 2009 at 8:40 a.m. (Eastern Time).

Lundemose will provide an overview on the company’s diabetes/obesity product portfolio and business developments.

The presentation will be webcast live and may be accessed by visiting OSI’s Web site at www.osip.com. A replay of the Webcast will also be available on the Company’s Web site until May 26, 2009.

OSI Pharmaceuticals discover, develop and commercialize high-quality, novel and differentiated personalized medicines designed to extend life and improve the quality of life for patients with cancer and diabetes/obesity.

This ad will auto-close in 10 seconds